Zobrazeno 1 - 10
of 110
pro vyhledávání: '"C Grataloup"'
Autor:
J. Riancho, D. Ferrao, S. Baron, C. Grataloup, G. Manceau, D. Rousseau, N. Gebara, M. Azizi, L. Amar
Publikováno v:
Annales d'Endocrinologie. 83:298-299
Autor:
E, Cornu, I, Belmihoub, N, Burnichon, C, Grataloup, F, Zinzindohoué, S, Baron, E, Billaud, M, Azizi, A-P, Gimenez-Roqueplo, L, Amar
Publikováno v:
La Revue de medecine interne. 40(11)
Phaeochromocytomas and paragangliomas (PPGL) are rare neuroendocrine tumors that arise from the adrenal medulla or sympathetic and parasympathetic ganglia. These tumors produce most often catecholamines in excess, causing hypertension and sometimes s
Autor:
Nelly Burnichon, Erika Cornu, Michel Azizi, Ines Belmihoub, E. Billaud, Anne-Paule Gimenez-Roqueplo, Stéphanie Baron, F. Zinzindohoué, Laurence Amar, C. Grataloup
Publikováno v:
La Revue de Médecine Interne
La Revue de Médecine Interne, Elsevier, 2019, 40, pp.733-741. ⟨10.1016/j.revmed.2019.07.008⟩
La Revue De Médecine Interne
La Revue De Médecine Interne, Elsevier, 2019, 40, pp.733-741. ⟨10.1016/j.revmed.2019.07.008⟩
La Revue de Médecine Interne, Elsevier, 2019, 40, pp.733-741. ⟨10.1016/j.revmed.2019.07.008⟩
La Revue De Médecine Interne
La Revue De Médecine Interne, Elsevier, 2019, 40, pp.733-741. ⟨10.1016/j.revmed.2019.07.008⟩
International audience; Phaeochromocytomas and paragangliomas (PPGL) are rare neuroendocrine tumors that arise from the adrenal medulla or sympathetic and parasympathetic ganglia. These tumors produce most often catecholamines in excess, causing hype
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a26729b2edebb2b66c9f6385b4b1105c
https://hal.science/hal-03488668
https://hal.science/hal-03488668
Autor:
J. Medioni, A. Hernigou, S. Ammari, Laure Fournier, Nathalie Siauve, C.A. Cuenod, C. Grataloup, Stéphane Oudard, Rokhaya Thiam
Publikováno v:
Journal de Radiologie Diagnostique et Interventionnelle. 95:527-540
Resume Les therapies ciblees ont considerablement ameliore le pronostic des patients atteints d’un cancer du rein metastatique (CCRm) mais on ne dispose pas de criteres d’evaluation de reponse fiables refletant les benefices cliniques car la regr
Autor:
Damien Bergerot, Stéphanie Baron, P.-.Y. Laffy, C. Bailly, Jean-Yves Pagny, Anne Blanchard, Laurence Amar, Pascal Houillier, Eliane Billaud, M. Azizi, T. Carreres, C. Grataloup, Y. Reznik, Franck Zinzindohoue, Erika Cornu
Publikováno v:
Journal of Hypertension. 37:e29
Objective:Adrenal venous sampling (AVS) is the gold standard to assess lateralization of aldosterone secretion in primary aldosteronism (PA). The selectivity index (SIcortisol, adrenal:peripheral cortisol ratio) determines correct catheter positionin
Autor:
Erika Cornu, Laurence Amar, M. Barigou, Anne-Marie Madjalian, Jean-Yves Pagny, Michel Azizi, Olivier Steichen, P.-.Y. Laffy, C. Grataloup, Stéphanie Baron, Franck Zinzindohoue, T. Carrere, G. Lethielleux
Publikováno v:
Journal of Hypertension. 35:e316-e317
Autor:
P. Bernadet-Monrozies, C. Bourillon, Anne-Laure Faucon, M. Azizi, Stéphanie Baron, Laurence Amar, Emmanuelle Vidal-Petiot, C. Grataloup
Publikováno v:
Journal of Hypertension. 36:e79
Autor:
M. Gueneret, Guy Meyer, N. Denarié, Gilles Chatellier, I. Podglajen, Joseph Emmerich, E. Abergel, Séverine Peyrard, A. Rodi, G. Kac, C. Grataloup
Publikováno v:
Journal of Hospital Infection. 65:163-168
Following 183 ultrasound examinations, a randomized trial was conducted to compare three procedures for disinfection of probes under routine conditions: dry wiping with a soft, dry, non-sterile paper towel, antiseptic wiping with a towel impregnated
Autor:
Stéphanie Baron, C. Grataloup, Franck Zinzindohoue, Erika Cornu, Olivier Steichen, Laurence Amar, Jy. Pagny, Luís Nogueira-Silva, P.-F. Plouin
Publikováno v:
Journal of Hypertension. 35:e316
Autor:
Laure Fournier, C. Grataloup, C.A. Cuenod, A. Hernigou, Rokhaya Thiam, S. Ammari, J. Medioni, Nathalie Siauve, Stéphane Oudard
Publikováno v:
Diagnostic and interventional imaging. 95(6)
Targeted therapies have considerably improved the prognosis of patients with metastatic renal cancer (mRCC) but there are no reliable response assessment criteria reflecting the clinical benefits, because there is no regression in size, or it is dela